Grifols (GRFS) Cash from Operations (QoQ) (2010 - 2020)

Grifols (GRFS) Cash from Operations (QoQ) (2010 - 2020) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Grifols	-	-	-

Historic Data

Download Data

Date	Value
Mar 31, 2020	-69.02%
Mar 31, 2019	-140.86%
Jun 30, 2018	63.97%
Mar 31, 2018	-83.05%
Jun 30, 2017	65.53%
Mar 31, 2017	-20.48%
Dec 31, 2016	-15.29%
Dec 31, 2015	74.54%
Sep 30, 2015	-20.91%
Jun 30, 2015	539.25%
Mar 31, 2015	104.71%
Dec 31, 2014	-194.08%
Sep 30, 2014	609.52%
Jun 30, 2014	-199.79%
Mar 31, 2014	-44.45%
Dec 31, 2013	172.06%
Sep 30, 2013	-53.85%
Jun 30, 2013	101.14%
Mar 31, 2013	-40.83%
Dec 31, 2012	23.34%